NM_005740.3:c.36T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005740.3(DNAL4):​c.36T>C​(p.Asp12Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.315 in 1,611,918 control chromosomes in the GnomAD database, including 84,416 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 8650 hom., cov: 32)
Exomes 𝑓: 0.31 ( 75766 hom. )

Consequence

DNAL4
NM_005740.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.248

Publications

22 publications found
Variant links:
Genes affected
DNAL4 (HGNC:2955): (dynein axonemal light chain 4) This gene encodes an axonemal dynein light chain which functions as a component of the outer dynein arms complex. This complex acts as the molecular motor that provides the force to move cilia in an ATP-dependent manner. The encoded protein is expressed in tissues with motile cilia or flagella and may be involved in the movement of sperm flagella. [provided by RefSeq, Dec 2014]
SUN2 (HGNC:14210): (Sad1 and UNC84 domain containing 2) SUN1 (MIM 607723) and SUN2 are inner nuclear membrane (INM) proteins that play a major role in nuclear-cytoplasmic connection by formation of a 'bridge' across the nuclear envelope, known as the LINC complex, via interaction with the conserved luminal KASH domain of nesprins (e.g., SYNE1; MIM 608441) located in the outer nuclear membrane (ONM). The LINC complex provides a direct connection between the nuclear lamina and the cytoskeleton, which contributes to nuclear positioning and cellular rigidity (summary by Haque et al., 2010 [PubMed 19933576]).[supplied by OMIM, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 22-38782696-A-G is Benign according to our data. Variant chr22-38782696-A-G is described in ClinVar as [Benign]. Clinvar id is 402791.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.248 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.657 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAL4NM_005740.3 linkc.36T>C p.Asp12Asp synonymous_variant Exon 2 of 4 ENST00000216068.9 NP_005731.1 O96015

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAL4ENST00000216068.9 linkc.36T>C p.Asp12Asp synonymous_variant Exon 2 of 4 1 NM_005740.3 ENSP00000216068.4 O96015
DNAL4ENST00000406199.3 linkc.36T>C p.Asp12Asp synonymous_variant Exon 2 of 3 2 ENSP00000385712.3 B0QXZ5
SUN2ENST00000406622.5 linkc.-138+11372T>C intron_variant Intron 1 of 18 2 ENSP00000383992.1 Q9UH99-1
DNAL4ENST00000486019.1 linkn.82-3083T>C intron_variant Intron 1 of 1 2

Frequencies

GnomAD3 genomes
AF:
0.327
AC:
49754
AN:
151994
Hom.:
8655
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.375
Gnomad AMI
AF:
0.335
Gnomad AMR
AF:
0.246
Gnomad ASJ
AF:
0.268
Gnomad EAS
AF:
0.676
Gnomad SAS
AF:
0.393
Gnomad FIN
AF:
0.223
Gnomad MID
AF:
0.266
Gnomad NFE
AF:
0.306
Gnomad OTH
AF:
0.300
GnomAD2 exomes
AF:
0.322
AC:
80391
AN:
249842
AF XY:
0.327
show subpopulations
Gnomad AFR exome
AF:
0.375
Gnomad AMR exome
AF:
0.187
Gnomad ASJ exome
AF:
0.266
Gnomad EAS exome
AF:
0.687
Gnomad FIN exome
AF:
0.230
Gnomad NFE exome
AF:
0.303
Gnomad OTH exome
AF:
0.299
GnomAD4 exome
AF:
0.313
AC:
457437
AN:
1459806
Hom.:
75766
Cov.:
35
AF XY:
0.316
AC XY:
229226
AN XY:
726264
show subpopulations
African (AFR)
AF:
0.380
AC:
12662
AN:
33350
American (AMR)
AF:
0.193
AC:
8572
AN:
44478
Ashkenazi Jewish (ASJ)
AF:
0.264
AC:
6895
AN:
26078
East Asian (EAS)
AF:
0.664
AC:
26255
AN:
39552
South Asian (SAS)
AF:
0.391
AC:
33591
AN:
85944
European-Finnish (FIN)
AF:
0.236
AC:
12586
AN:
53384
Middle Eastern (MID)
AF:
0.316
AC:
1812
AN:
5728
European-Non Finnish (NFE)
AF:
0.302
AC:
335679
AN:
1110974
Other (OTH)
AF:
0.321
AC:
19385
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
15606
31212
46818
62424
78030
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11242
22484
33726
44968
56210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.327
AC:
49764
AN:
152112
Hom.:
8650
Cov.:
32
AF XY:
0.323
AC XY:
24007
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.374
AC:
15532
AN:
41486
American (AMR)
AF:
0.246
AC:
3756
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.268
AC:
930
AN:
3472
East Asian (EAS)
AF:
0.676
AC:
3491
AN:
5166
South Asian (SAS)
AF:
0.392
AC:
1889
AN:
4824
European-Finnish (FIN)
AF:
0.223
AC:
2369
AN:
10602
Middle Eastern (MID)
AF:
0.265
AC:
78
AN:
294
European-Non Finnish (NFE)
AF:
0.306
AC:
20783
AN:
67962
Other (OTH)
AF:
0.299
AC:
632
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1688
3377
5065
6754
8442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
500
1000
1500
2000
2500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.317
Hom.:
33039
Bravo
AF:
0.329
Asia WGS
AF:
0.460
AC:
1596
AN:
3478
EpiCase
AF:
0.307
EpiControl
AF:
0.300

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
7.3
DANN
Benign
0.69
PhyloP100
0.25
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs760482; hg19: chr22-39178701; COSMIC: COSV53308873; COSMIC: COSV53308873; API